87 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
to Borrower on the Closing Date in an original principal amount equal to such Lender’s Commitment (the “Term Loan”). After repayment or prepayment (in whole … Date, Borrower shall pay to each Lender an amount equal to the product of (a) such Lender’s Commitment multiplied by (b) 0.03 (such product
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
ongoing commitment to driving top-line revenues, controlling operating expenses, advancing our pipeline, and improving our capital structure,” said Denny
8-K
EX-2.1
iis6uzw
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.1
szywl79ivz b6sp
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
1u13we85hru0rqy7olkg
27 Oct 23
Regulation FD Disclosure
4:19pm
424B3
y7gale90
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
7w1b kn5wfmdi6kpw6b
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
24ppsg8
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
dk3h9
16 Jun 23
Business combination disclosure
8:08am
425
79gdpzebwj54jxbx2a5
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
2sjjsn 3di83wv9t
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
75iclhw9 gukrdu
18 May 23
Other Events
5:02pm